Article Details
Retrieved on: 2020-12-29 12:22:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
GT Biopharma Inc's (OTCQB:GTBP) CEO commented that they "are pleased our HER2 TriKE™ therapeutic product candidate has shown good ...
Article found on: www.baystreet.ca
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here